CLINICAL_TRIALS
trial_result
· 2016-10-24
Clinical Trial Update: Study of the Efficacy and Safety of Empegfilgrastim for Neutropenia Prophylaxis in Breast Cancer Patients [Phase 3]
Summary
Phase 3 study assessing Empegfilgrastim for neutropenia prophylaxis in breast cancer patients undergoing chemotherapy; results were posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Biocad | Conditions: Chemotherapy-induced Neutropenia | Phase 3 | Status: COMPLETED | Results posted: 2016-10-24